Prevention of metabolic syndrome in serious mental illness

Psychiatr Clin North Am. 2011 Mar;34(1):109-25. doi: 10.1016/j.psc.2010.11.004.

Abstract

The interaction of lifestyle, socioeconomic status, genetic factors, and treatment with antipsychotic medications likely accounts for the high risk of metabolic syndrome, diabetes, heart disease, and premature mortality in people with serious mental illness. Given the high risk of developing diabetes and cardiovascular disease in persons with serious mental illness, psychiatrists who treat these individuals need to ensure they are familiar with these risks, monitor metabolic parameters in their patients, and educate their patients (and caregivers) about the risks and how to prevent them.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antipsychotic Agents / adverse effects
  • Humans
  • Mental Disorders / complications*
  • Metabolic Syndrome / chemically induced
  • Metabolic Syndrome / complications
  • Metabolic Syndrome / prevention & control*
  • Obesity / prevention & control
  • Preventive Health Services / methods
  • Primary Prevention / methods*

Substances

  • Antipsychotic Agents